Meningococcal Case Confirmed in Adelaide Infant
04 May 2026
The infection has been identified as serogroup B and is not connected to any earlier reported case.
Public health teams have traced close contacts of the child, with three people receiving preventive antibiotics to reduce any risk of infection spreading further.
In South Australia so far this year, there have been six confirmed meningococcal cases, compared with three at the same point in 2025. No deaths have been recorded in either year to date. All 2026 cases identified so far are serogroup B.
Early warning signs may include fever, headache, vomiting, stiff neck, and sensitivity to light. Some people may develop a rash of small red or purple spots that can quickly spread and resemble bruising.
In infants and young children, symptoms can be less specific and may include unusual irritability, difficulty waking, poor feeding, cold extremities, and a high-pitched cry.
Health authorities strongly advise seeking urgent medical care if any symptoms appear, as early treatment is critical.
Vaccination is available against several strains of meningococcal disease. In South Australia, free vaccines are provided for infants and adolescents through national and state programs. However, as vaccines do not cover all types, awareness of symptoms remains essential even for vaccinated individuals.
Contact management has been carried out according to national public health guidelines to limit any further transmission.
https://www.sahealth.sa.gov.au/
Source: SA Health